![]() ![]() The government has also urged Pfizer, Moderna and Johnson and Johnson to sell their shots to India. India this week gave emergency authorisation to Russia’s Sputnik V vaccine and imports to cover as many as 125 million people will start this month. Going by vaccination rates in the past week, that will last about nine days. ![]() ![]() The government said on Friday the country had a stock of about 26.7 million doses of vaccines. is the world's largest vaccine manufacturer by number of doses produced and sold globally (more than 1.5 billion doses), supplying the world's least expensive and WHO-accredited vaccines to as many as 170. India has administered the most doses in the world after the United States and China, but it ranks much lower per capita. Driven by the philanthropic philosophy of affordable vaccines, Serum Institute of India Pvt, Ltd. Many vaccination centres in India are now rationing supplies though they are only inoculating people above 45 years, having started the campaign in mid-January with front-line workers. Its total of 14.3 million infections since the pandemic began is the most after the United States. India has reported the most number of Covid-19 cases in the world this month. Oxford scientists said last week the main focus of initial tests was to ascertain not only whether the vaccine worked but that it induced good immune responses and no unacceptable side effects.Related Story India to fast-track approval for foreign vaccines amid second wave of Covid-19 infections Poonawalla said he hoped trials of the Oxford vaccine, due to finish in about September, would be successful. ![]() “But alongside COVID-19 vaccine development, we must continue to focus on routine immunisation for everyone and maintain the production of existing vaccines,” she said. More than 100 potential COVID-19 candidate vaccines are now under development by biotech and research teams around the world, and at least six of these are in preliminary testing in people in what are known as Phase 1 clinical trials.Ĭharlie Weller, head of vaccines at the UK-based global health charity The Wellcome Trust - which is seeking to ensure that COVID-19 funding and research efforts are global - said an effective COVID-19 vaccine would “save countless lives”. “Being a private limited company, not accountable to public investors or bankers, I can take a little risk and sideline some of the other commercial products and projects that I had planned in my existing facility,” Poonawalla said. That’s why we said we will go with this and that’s why we are confident,” Poonawalla told Reuters in a phone interview. “They are a bunch of very qualified, great scientists (at Oxford). While the Oxford vaccine, called “ChAdOx1 nCoV-19”, is yet to be proven to protect against COVID-19 infection, Serum decided to start making it after it had shown pre-clinical promise and had progressed into human trials, Serum Chief Executive Adar Poonawalla said. Some 3.05 million people have been reported to be infected globally, and by a Reuters tally 211,376 have so far died from COVID-19, the respiratory disease caused by the coronavirus. Serum, the world’s largest maker of vaccines by volume, is mass-producing the vaccine candidate developed by the University of Oxford, which started testing it on humans last week, and is a leader in the global race to develop an antidote to the novel coronavirus. NEW DELHI (Reuters) - The Serum Institute of India said on Tuesday it plans this year to produce up to 60 million doses of a potential vaccine against the new coronavirus that is under clinical trial in Britain. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |